433 related articles for article (PubMed ID: 7538250)
1. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
[TBL] [Abstract][Full Text] [Related]
2. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
Maunders MJ; Petti L; Rowe M
J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
[TBL] [Abstract][Full Text] [Related]
3. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection.
Buisson M; Morand P; Genoulaz O; Bourgeat MJ; Micoud M; Seigneurin JM
J Gen Virol; 1994 Feb; 75 ( Pt 2)():431-7. PubMed ID: 8113767
[TBL] [Abstract][Full Text] [Related]
4. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
Chen MR; Tsai CH; Wu FF; Kan SH; Yang CS; Chen JY
J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
6. The type-specific epitopes of the Epstein-Barr virus nuclear antigen 2 are near the carboxy terminus of the protein.
Rowe DT; Clarke JR
J Gen Virol; 1989 May; 70 ( Pt 5)():1217-29. PubMed ID: 2471806
[TBL] [Abstract][Full Text] [Related]
7. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.
Inoue N; Harada S; Honma T; Kitamura T; Yanagi K
Virology; 1991 May; 182(1):84-93. PubMed ID: 1850915
[TBL] [Abstract][Full Text] [Related]
8. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
[TBL] [Abstract][Full Text] [Related]
9. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
Ling PD; Ryon JJ; Hayward SD
J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG
Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.
Walling DM; Perkins AG; Webster-Cyriaque J; Resnick L; Raab-Traub N
J Virol; 1994 Dec; 68(12):7918-26. PubMed ID: 7966582
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
Allday MJ; MacGillivray AJ
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey.
Ohara N; Hayashi K; Teramoto N; Oka T; Fujimoto K; Yoshikawa Y; Castanos-Velez E; Biberfeld P; Akagi T
Intervirology; 2000; 43(2):102-6. PubMed ID: 10971128
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
Falk K; Linde A; Johnson D; Lennette E; Ernberg I; Lundkvist A
J Med Virol; 1995 Aug; 46(4):349-57. PubMed ID: 7595412
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
Cohen JI; Picchio GR; Mosier DE
J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
[TBL] [Abstract][Full Text] [Related]
16. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
Tong X; Yalamanchili R; Harada S; Kieff E
J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
[TBL] [Abstract][Full Text] [Related]
17. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1.
Stuber G; Dillner J; Modrow S; Wolf H; Székely L; Klein G; Klein E
Int Immunol; 1995 Apr; 7(4):653-63. PubMed ID: 7547693
[TBL] [Abstract][Full Text] [Related]
18. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
Levitsky V; Zhang QJ; Levitskaya J; Masucci MG
J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295
[TBL] [Abstract][Full Text] [Related]
19. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE
J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
